BIIB: Biogen Inc. Stock

by  •  • Comments Off on BIIB: Biogen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 17,341.57
Enterprise Value ($M) 21,041.07
Book Value ($M) 16,978.70
Book Value / Share 115.87
Price / Book 1.02
NCAV ($M) -3,428.40
NCAV / Share -23.40
Price / NCAV -5.06

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.10

Liquidity (mrq)
Quick Ratio 1.01
Current Ratio 1.44

Balance Sheet (mrq) ($M)
Current Assets 7,626.00
Assets 28,033.10
Liabilities 11,054.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9,675.90
Operating Income 2,344.20
Net Income 1,632.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,875.50
Cash from Investing -799.20
Cash from Financing -683.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13G/A BlackRock, Inc. 8.50 -14.61
11-12 13G/A Vanguard Group Inc 11.44 0.00
10-16 13G State Street Corp 5.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 174,761 1,515,735 11.53
2025-05-07 160,359 1,131,922 14.17
2025-05-06 316,094 1,399,634 22.58
2025-05-05 152,899 697,637 21.92

(click for more detail)

Similar Companies
BCRX – BioCryst Pharmaceuticals, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc.


Financial data and stock pages provided by
Fintel.io